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Abstract
Copyright © 2017 Raihan Shah Mahmud et al. Bacillus pumilus ribonuclease (binase) was shown
to be a promising antiviral agent in animal models and cell cultures. However, the mode of its
antiviral action remains unknown. To assess the binase effect on intracellular viral RNA we have
selected  single  stranded  negative-  and  positive-sense  RNA  viruses,  influenza  virus,  and
rhinovirus, respectively, which annually cause respiratory illnesses and are characterized by
high contagious nature, mutation rate, and antigen variability. We have shown that binase
exerts an antiviral effect on both viruses at the same concentration, which does not alter the
spectrum of  A549  cellular  proteins  and  expression  of  housekeeping  genes.  The  titers  of
influenza A (H1N1pdm) virus and human rhinovirus serotype 1A were reduced by 40% and 65%,
respectively. A preincubation of influenza virus with binase before infection significantly reduced
viral titer after single-cycle replication of the virus. Using influenza A virus mini genome system
we showed that  binase  reduced GFP  reporter  signaling  indicating  a  binase  action  on  the
expression of viral mRNA. Binase reduced the level of H1N1pdm viral NP mRNA accumulation in
A549 cells by 20%. Since the viral mRNA is a possible target for binase this agent could be
potentially  applied  in  the  antiviral  therapy  against  both  negative-  and positive-sense  RNA
viruses.
http://dx.doi.org/10.1155/2017/5279065
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